Sweden published its implementation law of the Medical Devices Regulation 2017/745, also applying to the In Vitro Devices Regulation 2017/746. This Act establishes several provisions under these two regulations and provides additional requirements by Swedish authorities. Namely, the main points of this law are the following:
Applicable fees and penalties
The Swedish law establishes multiple fees to be paid for those who apply to conduct or notify a clinical trial/performance study or report substantial amendments (Chapter 4 Section 1). Moreover, a fee is also applicable for those who apply for authorization to place in the . . .
Oh! It looks like you do not have access to this page.
Find the membership plan that suits you, and within a few minutes you are good to go.
Are you a member already? Log in here.